Application of methimazole serving in as and/or in preparation of metal beta-lactamase inhibitor
A technology of methimazole and lactamase, which is applied in the field of medicine, can solve problems such as methimazole that have not been reported yet, and achieve the effects of improving sensitivity, improving safety, and reversing drug resistance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Embodiment 1 Methimazole is to the determination of metallo-beta-lactamase inhibitory activity
[0047]After the substrate is hydrolyzed by the enzyme, the absorbance value will decrease. Therefore, the degree of substrate hydrolysis can be characterized by the change of absorbance, so as to judge the activity of the enzyme. Meropenem (50 μM) was used as the reporter substrate, and the absorbance change of the substrate after being hydrolyzed by metallo-β-lactamase was measured at a wavelength of 300 nm. The concentration of metallo-β-lactamase is 4nM, the buffer is 50mM HEPES (4-hydroxyethylpiperazineethanesulfonic acid), 0.1mM ZnSO 4 , pH=7.2, the reaction temperature is 25°C, and the specific experimental method is as follows:
[0048] 1. Determination of the inhibitory activity of methimazole on IMP-7 metallo-β-lactamases
[0049] (1) Dissolve methimazole in HEPES buffer and prepare different concentrations (0.1, 1, 10, 50, 100, 200, 300, 500 μM respectively), set...
Embodiment 2
[0063] Example 2 Evaluation of the combined use of methimazole and meropenem in inhibiting MBLs-producing resistant bacteria
[0064] The minimum inhibitory concentration (MIC) of methimazole combined with meropenem against MBLs resistant strains was determined by micro broth dilution method. The MBLs-producing strains used in the experiment were genetically engineered bacteria E.coli BL21(DE3) / pET28a-IMP-7, E.coli BL21(DE3) / pET28a-VIM-2 and E. .coli BL21(DE3) / pET28a-NDM-1.
[0065] FICI is used to judge the interaction when two drugs are used in combination, and is defined according to the following equation: FICI=FIC A +FIC B =C A / MIC A +C B / MIC B , where MIC A and MIC B are the MIC values of compounds A and B used alone, and C A and C B is the drug concentration of compounds A and B in the effective combination. If FICI ≤ 0.5, it is considered that the two drugs have synergistic effect, 0.5 < FICI ≤ 4 indicates that the synergistic effect of the two drugs is ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com